The next edition of the practical guide with regard to The Duty for Sponsor Oversight in Clinical Research was prepared to present in more detail the Risk Based Operational Data Review. As outlined in the previous edition of the practical guide, the definition of a threshold for missing data and or values was not explicit outlined, in the applicable regulatory binding documents, for example the Clinical trials - Regulation EU No 536/2014. This is also applicable for the upper limit or level of acceptance of, for example, protocol deviations, missing values and or values out of rang or missing safety visits. Nevertheless, the underlying regulations as well as reflexion papers and other articles provide the overall guidance, and required information for the determination of relevant protocol deviations, serious breaches and other deviations or issues. These should normally aligned to the defined outcome parameters of a clinical trial. The same applies for the patient safety, data integrity and data protection Therefore, the supplement edition was prepared for proposing a separate risk-based operational review.
The aim includes enhancing with the assumed procedure the quality of the data-set as required, for example, the AMNOG procedure in Germany and or accelerated approval.